GNRH1 and cancer: The GnRH-based chimeric proteins designed in the study selectively destroyed adenocarcinoma cells both in vitro and in vivo, which allowed them to conclude that the use of chimeric proteins for targeted therapy represented a novel therapeutic modality for the treatment of cancer in humans [67].